Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)

Piper Sandler lifted the terms people connected PROCEPT BioRobotics Corporation (NASDAQ:PRCT) to $35 from $28 connected April 30, maintaining an Overweight standing connected the shares and noting that the institution reported fiscal Q1 results that bushed connected the top-line and reiterated full-year guidance crossed each cardinal metrics. The steadfast further stated that the 4th was marked by beardown home superior placements with awesome all-time precocious ASPs, which resulted successful the banal trading up much than 10% aft hours.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) besides received a standing update from Baird the aforesaid day, with the steadfast lifting the terms people connected the banal to $28 from $27 and maintaining a Neutral standing connected the shares. The steadfast stated that it updated its exemplary aft its fiscal Q1 bushed results. However, it added that the semipermanent adoption trajectory is keeping them connected the sidelines.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is simply a commercial-stage surgical robotics institution that develops transformative solutions for urology. The institution manufactures and sells the AquaBeam Robotic System, which is an image-guided, surgical robotic strategy utilized successful minimally invasive urologic surgery.

While we admit the imaginable of PRCT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey connected Google News.